Annual CFF
Summary
- Current Value
- As of today, SGRY annual cash from financing is $262.00M, up +268.81% on
- Historical Performance
- SGRY annual cash from financing is down -17.17% over the past 3 years, and up +292.79% over the past 5 years
- All-Time High Comparison
- SGRY annual cash from financing is currently -65.87% below its historical high of $767.72M set on
- 3-Year Low Comparison
- SGRY annual cash from financing is +268.81% above its 3-year low of -$155.20M reached on
- Sector Comparison
- SGRY annual cash from financing is higher than 92.44% of companies in Healthcare sector
Cash From Financing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $262.00M | +268.8% | -17.2% | +292.8% | +708.4% | |
| Quarterly Cash From Financing | -$84.10M | -1052.0% | -75.2% | -224.6% | -581.2% | |
| TTM Cash From Financing | -$68.50M | -140.4% | -186.9% | -174.5% | -454.8% | |
| Price | $16.12 | -24.1% | -43.6% | -46.8% | – | |
| Annual Cash From Operations | $300.10M | +2.1% | +244.6% | +131.7% | +547.1% | |
| Annual Cash From Investing | -$488.50M | -116.5% | -47.3% | -473.4% | -10000.0% | |
| Annual Dividends Paid | $0.00 | 0.0% | -100.0% | 0.0% | 0.0% | |
| Annual Total Debt | $3.70B | +21.0% | +12.4% | +27.7% | +100.0% | |
| Shares Outstanding | 129.34M | +1.8% | +2.7% | +156.3% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $262.00M | at high | |
| 5Y | $316.30M | -17.2% | |
| All | $767.72M | -65.9% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$155.20M | +268.8% | |
| 5Y | -$155.20M | +268.8% | |
| All | -$155.20M | +268.8% |
Cash From Financing History
FAQ
What is the current annual cash from financing of SGRY?
As of today, SGRY annual cash from financing is $262.00M
What is 1-year change in SGRY annual cash from financing?
SGRY annual cash from financing is up +268.81% year-over-year
What is 3-year change in SGRY annual cash from financing?
SGRY annual cash from financing is down -17.17% over the past 3 years
How far is SGRY annual cash from financing from its all-time high?
SGRY annual cash from financing is currently -65.87% below its historical high of $767.72M set on December 31, 2017
How does SGRY annual cash from financing rank versus sector peers?
SGRY annual cash from financing is higher than 92.44% of companies in Healthcare sector
When is SGRY next annual earnings release?
The next annual earnings release for SGRY is on
Quarterly CFF
Summary
- Current Value
- As of today, SGRY quarterly cash from financing is -$84.10M, down -34.35% on
- Historical Performance
- SGRY quarterly cash from financing is down -1052.05% year-over-year, and down -75.21% over the past 3 years
- All-Time High Comparison
- SGRY quarterly cash from financing is currently -109.88% below its historical high of $851.01M set on
- 3-Year Low Comparison
- SGRY quarterly cash from financing is at its 3-year low
- Sector Comparison
- SGRY quarterly cash from financing is higher than 6.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$84.10M | -34.4% | -1052.0% | -75.2% | -224.6% | |
| Annual Cash From Financing | $262.00M | – | +268.8% | -17.2% | +292.8% | |
| TTM Cash From Financing | -$68.50M | -925.3% | -140.4% | -186.9% | -174.5% | |
| Price | $16.12 | -20.7% | -24.1% | -43.6% | -46.8% | |
| Quarterly Cash From Operations | $83.60M | +2.8% | +28.2% | +181.5% | +210.8% | |
| Quarterly Cash From Investing | -$46.20M | -2300.0% | +6.8% | +14.9% | -257.7% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $3.87B | -0.2% | +10.0% | +9.8% | +22.2% | |
| Shares Outstanding | 129.34M | – | +1.8% | +2.7% | +156.3% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $48.00M | N/A | -275.2% |
| 3Y | $193.10M | N/A | -143.6% |
| 5Y | $229.80M | -136.6% | |
| All | $851.01M | -109.9% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$84.10M | at low | |
| 3Y | -$84.10M | at low | |
| 5Y | -$84.10M | at low | |
| All | -$84.10M | at low |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of SGRY?
As of today, SGRY quarterly cash from financing is -$84.10M
What is SGRY quarterly cash from financing most recent change?
SGRY quarterly cash from financing was down -34.35% on September 30, 2025
What is 1-year change in SGRY quarterly cash from financing?
SGRY quarterly cash from financing is down -1052.05% year-over-year
How far is SGRY quarterly cash from financing from its all-time high?
SGRY quarterly cash from financing is currently -109.88% below its historical high of $851.01M set on September 30, 2017
How does SGRY quarterly cash from financing rank versus sector peers?
SGRY quarterly cash from financing is higher than 6.81% of companies in Healthcare sector
When is SGRY next earnings release?
The next earnings release for SGRY is on
TTM CFF
Summary
- Current Value
- As of today, SGRY TTM cash from financing is -$68.50M, down -925.30% on
- Historical Performance
- SGRY TTM cash from financing is down -140.44% year-over-year, and down -186.93% over the past 3 years
- All-Time High Comparison
- SGRY TTM cash from financing is currently -108.32% below its historical high of $823.53M set on
- 3-Year Low Comparison
- SGRY TTM cash from financing is +55.86% above its 3-year low of -$155.20M reached on
- Sector Comparison
- SGRY TTM cash from financing is higher than 12.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$68.50M | -925.3% | -140.4% | -186.9% | -174.5% | |
| Annual Cash From Financing | $262.00M | – | +268.8% | -17.2% | +292.8% | |
| Quarterly Cash From Financing | -$84.10M | -34.4% | -1052.0% | -75.2% | -224.6% | |
| Price | $16.12 | -20.7% | -24.1% | -43.6% | -46.8% | |
| TTM Cash From Operations | $282.30M | +7.0% | +12.3% | +64.8% | +7.2% | |
| TTM Cash From Investing | -$232.20M | +1.4% | +46.6% | +45.5% | -1298.8% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $3.87B | -0.2% | +10.0% | +9.8% | +22.2% | |
| Shares Outstanding | 129.34M | – | +1.8% | +2.7% | +156.3% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $262.00M | N/A | -126.2% |
| 3Y | $262.00M | -126.2% | |
| 5Y | $316.30M | -121.7% | |
| All | $823.53M | -108.3% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$68.50M | at low | |
| 3Y | -$155.20M | +55.9% | |
| 5Y | -$155.20M | +55.9% | |
| All | -$171.58M | +60.1% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of SGRY?
As of today, SGRY TTM cash from financing is -$68.50M
What is SGRY TTM cash from financing most recent change?
SGRY TTM cash from financing was down -925.30% on September 30, 2025
What is 1-year change in SGRY TTM cash from financing?
SGRY TTM cash from financing is down -140.44% year-over-year
How far is SGRY TTM cash from financing from its all-time high?
SGRY TTM cash from financing is currently -108.32% below its historical high of $823.53M set on September 30, 2017
How does SGRY TTM cash from financing rank versus sector peers?
SGRY TTM cash from financing is higher than 12.62% of companies in Healthcare sector
When is SGRY next earnings release?
The next earnings release for SGRY is on
Cash From Financing Formula
Data Sources & References
- SGRY Official Website www.surgerypartners.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1638833/000163883325000163/0001638833-25-000163-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1638833/000163883325000053/0001638833-25-000053-index.htm
- SGRY Profile on Yahoo Finance finance.yahoo.com/quote/SGRY
- SGRY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgry
